Effects of Helicobacter pylori treatment on rosacea: A single-arm clinical trial study

Journal of Dermatology

Volumn 44, Issue 9, 2017, Pages 1033-1037

  Saleh, Parviz ^a   Naghavi Behzad, Mohammad ^b   Herizchi, Hamdieh ^b   Mokhtari, Fatemeh ^b   Mirza Aghazadeh Attari, Mohammad ^b   Piri, Reza ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

eradication; Helicobacter pylori; prevalence; rosacea; treatment

Indexed keywords

CLARITHROMYCIN; METRONIDAZOLE; PANTOPRAZOLE; ANTIINFECTIVE AGENT;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL CLEARANCE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONCURRENT INFECTION; DISEASE ASSOCIATION; DISEASE COURSE; DULUTH ROSACEA GRADING SCORE; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; ROSACEA; SCORING SYSTEM; SEX DIFFERENCE; SKIN DISEASE ASSESSMENT; TELANGIECTASIA; TREATMENT OUTCOME; CHRONIC DISEASE; DRUG EFFECT; HELICOBACTER PYLORI; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; SEX FACTOR;

ADULT; AGE FACTORS; ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; ROSACEA; SEX FACTORS;

EID: 85018284943     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.13878     Document Type: Article

References (36)

1. Plewig G, Kligman AM. Acne and Rosacea. Berlin: Springer Science & Business Media, 2012.
2. Powell FC. Rosacea. N Engl J Med 2005; 352: 793–803.
3. Tan J, Blume-Peytavi U, Ortonne J et al. An observational cross-sectional survey of rosacea: clinical associations and progression between subtypes. Br J Dermatol 2013; 169: 555–562.
4. Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol 2013; 69: S27–S35.
5. Steinhoff M, Buddenkotte J, Aubert J et al. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. In: Journal of Investigative Dermatology Symposium Proceedings: Nature Publishing Group, 2011: 2–11.
6. Del Rosso JQ. Advances in understanding and managing rosacea: part 1 connecting the dots between pathophysiological mechanisms and common clinical features of rosacea with emphasis on vascular changes and facial erythema. J Clin Aesthet Dermatol 2012; 5: 16–25.
7. Fimmel S, Abdel-Naser MB, Kutzner H et al. New aspects of the pathogenesis of rosacea. Drug Discov Today Dis Mech 2008; 5: e103–e111.
8. Pouralibaba F, Babaloo Z, Pakdel F et al. Serum level of interleukin 17 in patients with erosive and non erosive oral lichen planus. J Dent Res Dent Clin Dent Prospects 2013; 7: 91.
9. Naderi NJ, Tirgari F, Esmaili F et al. Vascular endothelial growth factor and Ki-67 antigen expression in relation to age and gender in oral squamous cell carcinoma. J Dent Res Dent Clin Dent Prospects 2012; 6: 103.
10. Tisma VS, Basta-Juzbasic A, Jaganjac M et al. Oxidative stress and ferritin expression in the skin of patients with rosacea. J Am Acad Dermatol 2009; 60: 270–276.
11. Guzman-Sanchez DA, Ishiuji Y, Patel T et al. Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 2007; 57: 800–805.
12. Marks R. The enigma of rosacea. J Dermatolog Treat 2007; 18: 326–328.
13. Lacey N, Delaney S, Kavanagh K et al. Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 2007; 157: 474–481.
14. Golfroushan F, Azimi H, Ali ETH. Comparison of efficacy of topical combination solution of salicylic acid% 2 and erythromycin% 4 with topical solution of erythromycin 4% alone in mild to moderate acne vulgaris treatment: a double-blinded randomized clinical trial. Med J Tabriz Univ Med Sci Health Serv 2013; 34: 18–21.
15. Zandi S, Shamsadini S, Zahedi M et al. Helicobacter pylori and rosacea. Eastern Mediterranean health journal= La revue de sante de la Mediterranee orientale= al-Majallah al-sihhiyah li-sharq al-mutawassit 2002: 9: 167–171.
16. Hernando-Harder AC, Booken N, Goerdt S et al. Helicobacter pylori infection and dermatologic diseases. Eur J Dermatol 2009; 19: 431–444.
17. El-Khalawany M, Mahmoud A, Mosbeh AS et al. Role of Helicobacter pylori in common rosacea subtypes: a genotypic comparative study of Egyptian patients. J Dermatol 2012; 39: 989–995.
18. Bhattarai S, Agrawal S, Rijal A et al. The study of prevalence of Helicobacter pylori in patients with acne rosacea. Kathmandu Univ Med J 2014; 10: 49–52.
19. Prelipcean CC, Mihai C, Gogălniceanu P et al. Extragastric manifestations of Helicobacter pylori infection. Rev Med Chir Soc Med Nat Iasi 2006; 111: 575–583.
20. Yousefi L, Ghotaslou R, Akhi MT et al. Frequency of Helicobacter pylori blood-group antigen-binding adhesion 2 and sialic acid binding adhesion genes among dyspeptic patients in Tabriz, Iran: H. pylori babA2 and sabA genes. J Analyt Res Clin Med 2015; 3: 71–76.
21. Salehi MR, Aboei MS, Naghsh N et al. A comparison in prevalence of Helicobacter pylori in the gingival crevicular fluid from subjects with periodontitis and healthy individuals using polymerase chain reaction. J Dent Res Dent Clin Dent Prospects 2013; 7: 238.
22. Szlachcic A. The link between Helicobacter pylori infection and rosacea. J Eur Acad Dermatol Venereol 2002; 16: 328–333.
23. Tüzün Y, Keskin S, Kote E. The role of Helicobacter pylori infection in skin diseases: facts and controversies. Clin Dermatol 2010; 28: 478–482.
24. Daković Z, Vesić S, Vuković J et al. Ocular rosacea and treatment of symptomatic Helicobacter pylori infection: a case series. Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2007; 16: 83–86.
25. Mayr-Kanhäuser S, Kränke B, Kaddu S et al. Resolution of granulomatous rosacea after eradication of Helicobacter pylori with clarithromycin, metronidazole and pantoprazole. Eur J Gastro Hepatol 2001; 13: 1379–1383.
26. Wilkin J, Dahl M, Detmar M et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol 2004; 50: 907–912.
27. Chisholm SA, Watson CL, Teare EL et al. Non-invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits? J Med Microbiol 2004; 53: 623–627.
28. Kyriakis KP, Palamaras I, Terzoudi S et al. Epidemiologic aspects of rosacea. J Am Acad Dermatol 2005; 53: 918–919.
29. Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol 2013; 69: S27–S35.
30. McAleer MA, Fitzpatrick P, Powell FC. Papulopustular rosacea: prevalence and relationship to photodamage. J Am Acad Dermatol 2010; 63: 33–39.
31. Abram K, Silm H, Oona M. Prevalence of rosacea in an Estonian working population using a standard classification. Acta Dermato-Venereologica 2010; 90: 269–273.
32. Argenziano G, Donnarumma G, Arnese P et al. Incidence of anti-Helicobacter pylori and anti-CagA antibodies in rosacea patients. Int J Dermatol 2003; 42: 601–604.
33. Abram K, Silm H, Maaroos HI et al. Risk factors associated with rosacea. J Eur Acad Dermatol Venereol 2010; 24: 565–571.
34. Rojo-Garcia JM, Munoz-Perez MA, Escudero J et al. Helicobacter pylori in rosacea and chronic urticaria. Acta dermato-venereologica 2000; 80: 156–157.
35. Bamford JT, Tilden RL, Blankush JL et al. Effect of treatment of Helicobacter pylori infection on rosacea. Arch Dermatol 1999; 135: 659–663.
36. Herr C, Hee You C. Relationship between Helicobacter pylori and Rosacea. J Korean Med Sci 2000; 15: 551–554.